眼科

• 论著 • 上一篇    下一篇

吸烟对甲状腺相关眼病患者眶脂肪分化的影响

周哲 高玉 孙琰 景明 胡佳丽   

  1. 200081 上海, 解放军第四一一医院眼科
  • 收稿日期:2015-12-17 出版日期:2016-09-25 发布日期:2016-09-26
  • 通讯作者: 胡佳丽,Email: shalley1@hotmail.com

Smoking increases adipogenesis of orbital fatty tissue in patients with thyriod-associated ophthalmopathy

ZHOU Zhe, GAO Yu, SUN Yan, JING Ming, HU Jia-l   

  1. Department of Ophthalmology, No. 411 Hospital of PLA, Shanghai 200081, China
  • Received:2015-12-17 Online:2016-09-25 Published:2016-09-26
  • Contact: HU Jia-li, Email: shalley1@hotmail.com

摘要:

目的 确定吸烟对甲状腺相关眼病(TAO)患者眶脂肪分化的影响。设计 回顾性病例系列。 研究对象 2012年6-12月在上海长征医院眼科行眶减压术的TAO患者40例,男性27例,女性13例。方法 40例TAO患者中,21例吸烟、8例曾吸烟但已戒烟,5例被动吸烟,6例非吸烟。运用RT-PCR检测所有患者眶脂肪CCAAT/增强结合蛋白(C/EBP)和过氧化物酶体增生物激活受体(PPARγ) mRNA表达量。用△Ct法进行其各基因表达的相对定量。多组间的总体比较采用单因素方差分析,随后用SNK-q检验进行两两比较。主要指标 C/EBP和PPARγ mRNA表达量。结果 吸烟组患者的C/EBP(12.04±4.26) 和PPARγ mRNA表达量(4.82±1.41)明显高于非吸烟组(C/EBP:2.32±0.92;PPARγ:1.37±0.25)(P<0.001)。同时,曾吸烟组和被动吸烟组的C/EBP(4.29±1.26,5.76±1.03)和PPARγ mRNA表达量(2.91±1.23,3.22±0.50)对比非吸烟组的差异也具有统计学意义(曾吸烟组C/EBP P=0.039,PPARγ P=0.047;被动吸烟组C/EBP P=0.002,PPARγ P=0.002)。吸烟指数≥100年支的TAO患者眶脂肪C/EBP(14.28±3.61)和PPARγ mRNA(5.65±1.02)高于吸烟指数<100年支的患者(C/EBP: 8.42±2.30;PPARγ: 3.48±0.74)(P均<0.01)。结论 眶脂肪C/EBP 和PPARγ mRNA的表达量与吸烟史有关。(眼科,2016, 25: 334-338)

关键词: 吸烟, 甲状腺相关眼病, CCAAT/增强结合蛋白, 过氧化物酶体增生物激活受体

Abstract:

Objective To determine whether smoking increases adipogenesis of the orbital fatty tissue in patients with thyriod associated ophthalmopathy(TAO). Design Retrospective case series. Participants 40 patients (21 smokers, 8 ex-smokers, 5 passive smokers and 6 nonsmokers) were enrolled. Methods The expression levels of CCAAT/enhancer binging protein(C/EBP) and peroxisome proliferciter-activated receptor γ(PPARγ) of orbital fatty tissue were measured using real-time PCR. Main Outcome Measures C/EBP and PPARγ mRNA expressions. Results Orbital C/EBP and PPARγ mRNA expressions significantly increased in patients with history of smoking (C/EBP: smoker 12.04±4.26 vs non-smoker 2.32±0.92; PPARγ: smoker 4.82±1.41 vs non-smoker 1.37±0.25) (P<0.001), and their expression of ex-smokers and passive smokers were higher than nonsmokers (C/EBP: 4.29±1.26, 5.76±1.03; PPARγ: 2.91±1.23, 3.22±0.50; all P<0.05). Additionally, we found that the expressions of C/EBP (14.28±3.61) and PPARγ mRNA (5.65±1.02) in orbital adipose tissues from TAO patients with higher smoking index(≥100 cigarettes/day years) increased compared with those with lower smoking index(<100 cigarettes/day years)( C/EBP 8.42±2.30;PPARγ 3.48±0.74)(P<0.01). Conclusion Our study suggests that smoking at presentation for TAO increases the levels of C/EBP and PPARγ. (Ophthalmol CHN, 2016, 25: 334-338)

Key words: smoking, thyriod-associated ophthalmopathy, CCAAT/enhancer binging protein(C/EBP), peroxisome proliferciter-activated receptor γ(PPARγ)